Literature DB >> 17545479

Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium.

Ramesh Natarajan1, Fadi N Salloum, Bernard J Fisher, Evan D Ownby, Rakesh C Kukreja, Alpha A Fowler.   

Abstract

Emerging research suggests that oxidant-driven transcription of key cytokine/chemokine networks within the myocardium plays a crucial role in producing ischemia-reperfusion (I/R) injury. We recently showed that activation of hypoxia-inducible factor-1 (HIF-1) attenuated cardiac I/R injury. Diminished injury in these prior studies was associated with significant reductions in circulating interleukin-8 levels, suggesting that HIF-1 may play an important role in modulating postischemic cardiac inflammation. In the current study, we examined the role of HIF-1 activation in modulating proinflammatory chemokine [macrophage inflammatory protein (MIP)-2, cytokine-induced neutrophil chemoattractant factor (KC), and lipopolysaccharide-induced CXC chemokine (LIX)] and adhesion molecule [intercellular adhesion molecule (ICAM)-1] expression in murine cardiomyocytes in vitro (HL-1 cell line) and in intact murine hearts following in vivo I/R injury. Our results show that HIF-1 activation induced both pharmacologically by the prolyl hydroxylase inhibitor dimethyloxallyl glycine and via small-interfering RNA (siRNA)-mediated prolyl-4 hydroxylase-2 (P4HA2) gene silencing significantly attenuated tumor necrosis factor-alpha-induced chemokine (KC and LIX) and ICAM-1 expression in cardiomyocytes. In vivo, postischemic hearts obtained from animals receiving the P4HA2 siRNA (HIF-1 activation) exhibited significantly reduced CXC chemokine (MIP-2, KC, and LIX), CC chemokine (monocyte chemoattractant protein-1), and ICAM-1 expression when compared with postischemic hearts from either saline I/R controls or postischemic hearts from animals receiving a nontargeting control siRNA (no HIF-1 activation). Diminished chemokine and adhesion molecule expression in HIF-1-activated postischemic hearts was associated with significantly reduced polymorphonuclear leukocyte infiltration and myocardial infarct size (>60% reduction P4HA2 siRNA I/R vs. saline I/R, P < 0.001, n = 6). In conclusion, these results demonstrate for the first time that HIF-1 activation following infusion of siRNA to P4HA2 plays a key role in modulating I/R-associated cardiac inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545479     DOI: 10.1152/ajpheart.00291.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  25 in total

1.  Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury.

Authors:  Simon A Hirota; Kyla Fines; Jeffrey Ng; Danya Traboulsi; Josh Lee; Eikichi Ihara; Yan Li; William G Willmore; Daniel Chung; Melanie M Scully; Thomas Louie; Shaun Medlicott; Manigandan Lejeune; Kris Chadee; Glen Armstrong; Sean P Colgan; Daniel A Muruve; Justin A MacDonald; Paul L Beck
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

Review 2.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

3.  Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase.

Authors:  Xiao-Li Zhang; Zhen-Wen Yan; Wei-Wen Sheng; Jing Xiao; Zhen-Xing Zhang; Zhi-Bin Ye
Journal:  Mol Cell Biochem       Date:  2011-07-14       Impact factor: 3.396

Review 4.  Antisense makes sense in engineered regenerative medicine.

Authors:  Yongchang Yao; Chunming Wang; Rohan R Varshney; Dong-An Wang
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

5.  Prolyl-4-hydroxylase domain protein 2 controls NF-κB/p65 transactivation and enhances the catabolic effects of inflammatory cytokines on cells of the nucleus pulposus.

Authors:  Jun Li; Wen Yuan; Shuai Jiang; Wei Ye; Hao Yang; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

6.  Prolyl hydroxylases positively regulated LPS-induced inflammation in human gingival fibroblasts via TLR4/MyD88-mediated AKT/NF-κB and MAPK pathways.

Authors:  Lingling Shang; Ting Wang; Dongdong Tong; Wenyan Kang; Qianyu Liang; Shaohua Ge
Journal:  Cell Prolif       Date:  2018-08-09       Impact factor: 6.831

7.  Short hairpin RNA interference therapy for ischemic heart disease.

Authors:  Mei Huang; Denise A Chan; Fangjun Jia; Xiaoyan Xie; Zongjin Li; Grant Hoyt; Robert C Robbins; Xiaoyuan Chen; Amato J Giaccia; Joseph C Wu
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

8.  HIF-1α in heart: protective mechanisms.

Authors:  Joe Wu; Ping Chen; Ying Li; Chris Ardell; Tatyana Der; Ralph Shohet; Minghua Chen; Gary L Wright
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-19       Impact factor: 4.733

9.  The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts.

Authors:  Kathrin Rychli; Christoph Kaun; Philipp J Hohensinner; Adrian J Dorfner; Stefan Pfaffenberger; Alexander Niessner; Michael Bauer; Wolfgang Dietl; Bruno K Podesser; Gerald Maurer; Kurt Huber; Johann Wojta
Journal:  J Cell Mol Med       Date:  2010-01       Impact factor: 5.310

Review 10.  Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases.

Authors:  Kathryn M Oliver; Cormac T Taylor; Eoin P Cummins
Journal:  Arthritis Res Ther       Date:  2009-02-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.